VANDA PHARMACEUTICALS INC. Restricted Cash and Cash Equivalents, Noncurrent
VANDA PHARMACEUTICALS INC. (VNDA) had Restricted Cash and Cash Equivalents, Noncurrent of $366.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2026-08-06
- 2026-06-30: Restricted Cash and Cash Equivalents, Noncurrent $366.00K.
- 2026-03-31: Restricted Cash and Cash Equivalents, Noncurrent $366.00K.
- 2025-12-31: Restricted Cash and Cash Equivalents, Noncurrent $366.00K.
- 2025-09-30: Restricted Cash and Cash Equivalents, Noncurrent $366.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent | Restricted Cash and Cash Equivalents, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $366.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $366.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $366.00K 10-K · filed 2026-02-12 | |
| 2025-09-30 | $366.00K 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $469.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $469.00K 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $469.00K 10-K · filed 2026-02-12 | |
| 2024-09-30 | $469.00K 10-Q · filed 2025-10-30 | |
| 2015-09-30 | $813.00K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $813.00K 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $813.00K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $813.00K 10-Q · filed 2015-11-04 | $785.00K 10-K · filed 2015-03-13 |
| 2014-09-30 | $785.00K 10-Q · filed 2014-10-27 | |
| 2014-06-30 | $785.00K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $785.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $500.00K 10-K · filed 2015-03-13 | |
| 2013-09-30 | $500.00K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $600.00K 10-Q · filed 2013-07-31 | |
| 2013-03-31 | $600.00K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $600.00K 10-K · filed 2014-02-25 | |
| 2012-09-30 | $600.00K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $1.03M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $1.03M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $600.00K 10-K · filed 2014-02-25 | $1.03M 10-K · filed 2012-03-09 |
| 2011-09-30 | $1.03M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $530.00K 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $430.00K 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |